Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 344-65-0 | MDL No. : | MFCD00010308 |
Formula : | C7H3BrClF3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OSTIALFVJOFNPP-UHFFFAOYSA-N |
M.W : | 259.45 | Pubchem ID : | 136172 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 44.15 |
TPSA : | 0.0 Ų |
GI absorption : | Low |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.0 cm/s |
Log Po/w (iLOGP) : | 2.42 |
Log Po/w (XLOGP3) : | 4.06 |
Log Po/w (WLOGP) : | 5.27 |
Log Po/w (MLOGP) : | 4.66 |
Log Po/w (SILICOS-IT) : | 4.17 |
Consensus Log Po/w : | 4.12 |
Lipinski : | 1.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.31 |
Solubility : | 0.0127 mg/ml ; 0.0000489 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -3.76 |
Solubility : | 0.0446 mg/ml ; 0.000172 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.75 |
Solubility : | 0.00456 mg/ml ; 0.0000176 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.52 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | Stage #1: With hydrogenchloride; sodium nitrite In water at 0 - 5℃; for 1 h; Stage #2: With copper(l) chloride In water at 20 - 70℃; |
The diazonium salt solution was prepared as exemplified in example 3. The cold diazonium salt solution was poured into the well stirred and cooled mixture of CuCl (8.9gm., 0.091moles) in concentrated hydrochloric acid (46gm., 0.44moles). The cold mixture is allowed to warm up to room temperature and stirring is continued for 2 to 3 hours. Further heat the reaction mixture to 60 - 70°C to complete the reaction and title compound was isolated. Yield (percent): 65percent |
[ 1099597-32-6 ]
2-Bromo-4-chlorobenzotrifluoride
Similarity: 0.96
[ 384-16-7 ]
2-Bromo-1-chloro-3-(trifluoromethyl)benzene
Similarity: 0.94
[ 402-04-0 ]
1-Bromo-2-chloro-4-trifluoromethylbenzene
Similarity: 0.91
[ 928783-85-1 ]
1-Bromo-3-chloro-5-(trifluoromethyl)benzene
Similarity: 0.91
[ 454-78-4 ]
2-Bromo-1-chloro-4-(trifluoromethyl)benzene
Similarity: 0.89
[ 1099597-32-6 ]
2-Bromo-4-chlorobenzotrifluoride
Similarity: 0.96
[ 384-16-7 ]
2-Bromo-1-chloro-3-(trifluoromethyl)benzene
Similarity: 0.94
[ 402-04-0 ]
1-Bromo-2-chloro-4-trifluoromethylbenzene
Similarity: 0.91
[ 928783-85-1 ]
1-Bromo-3-chloro-5-(trifluoromethyl)benzene
Similarity: 0.91
[ 454-78-4 ]
2-Bromo-1-chloro-4-(trifluoromethyl)benzene
Similarity: 0.89